The chart below shows how WRB performed 10 days before and after its earnings report, based on data from the past quarters. Typically, WRB sees a -1.77% change in stock price 10 days leading up to the earnings, and a +0.53% change 10 days following the report. On the earnings day itself, the stock moves by +0.25%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Strong Return on Equity: Record full year 2024 results with return on equity of 23.6% and operating return on equity of 22.4%.
Operating Earnings Surge: Operating earnings increased 15.5% to $453 million, or $1.13 per share, with an operating return on equity of 24.3%.
Quarterly Net Income Surge: Net income for the quarter rose 45% to $576 million, or $1.44 per share, achieving a return on equity of 30.9%.
Premiums Written Growth: Gross and net premiums written grew 9.6% to $9.3 billion, with the insurance segment's net premiums written increasing 9.9% to over $2.6 billion.
Stockholders' Equity Increase: Stockholders' equity increased 12.6% to $840 million, supported by record net income of $180 million and $67 million in share repurchases.
Negative
Loss Ratio Increase: The current accident year loss ratio increased slightly to 59.2%, indicating a deterioration in underwriting performance compared to the previous year.
Catastrophe Losses Increase: Catastrophe losses rose significantly, primarily due to Hurricane Milton, contributing to a 1.4 loss ratio point increase quarter over quarter.
Casualty Reinsurance Decline: The casualty reinsurance segment experienced a decline of approximately 15% in net written premiums, reflecting a challenging pricing environment and lack of market discipline.
Expense Ratio Stability: The expense ratio remained flat at 28.4%, which, while stable, indicates ongoing pressure on cost management in a competitive market.
Impact of Social Inflation: Social inflation continues to impact the liability market, with increased claims costs and jury awards, particularly in auto liability and medical malpractice, posing risks to future profitability.
Earnings call transcript: WR Berkley beats Q4 2024 forecasts, stock rises
WRB.N
1.19%